Exercise may extend survival in brain cancer
A recent study of patients with recurrent malignant glioma revealed exercise behavior to be a strong independent predictor of survival.
Diagnosis & Disease Information
Modified stem cells protect healthy tissue from brain cancer treatment
Glioblastoma treatment may be made more effective by introducing a chemotherapy-resistant gene into normal bone marrow stem cells to protect them from the toxic effects of chemotherapy.
Childhood cancer survivors more likely to have future GI problems
People who underwent cancer therapy as children have a heightened risk of developing gastrointestinal (GI) complications later in life, a new study shows.
New treatments for pancreatic cancer
FOLFIRINOX was more effective than gemcitabine in increasing survival and delaying disease progression in metastatic pancreatic cancer, plus new indications for everolimus and sunitinib.
Portable glioblastoma treatment device receives approval
The FDA has approved a portable therapeutic system that can be used at home by adults who have glioblastoma that has recurred or progressed following chemotherapy and radiotherapy.
Overall cancer mortality rates decrease, but incidence of some cancers increases
Overall, cancer incidence rates fell approximately 1% annually and overall death rates decreased by an average of 1.6% annually between 2003 and 2007.
Bradykinin 2 receptor may stop glioma invasion
A laboratory version of a drug approved for use in Europe successfully stopped malignant brain-tumor cells from finding the blood vessels they need to thrive.
Low increased risk of second cancer after radiotherapy
Only a relatively small proportion of second cancers in adults is related to routine radiotherapy administered for initial disease, according to the findings of a recent study.
Gene deletion may explain many cases of glioblastoma
An important gene deletion appears to occur in as many as 1 of every 4 cases of glioblastoma—the most common adult brain cancer—scientists have found.
FDA moves to withdraw breast-cancer indication for Avastin
The FDA today recommended to remove the breast-cancer indication from the label of Avastin (bevacizumab) after reviewing the results of four clinical studies.
- Loading...
Loading...
Loading... 
Loading...